Delivery Order SPE2DB22D3016-SPE2DB24FBBJ7

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,529.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567722359 MESALAMINE DR 1.2 GM TABLET 120S, a medical product, and has an ultimate completion date of March 31, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with...
This federal contract award, valued at $5,417.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565091177 - MESALAMINE 800 MG DR TABLET 180S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 9, 2024. The award is associated with a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,150.13 firm fixed price delivery order is for the supply of MESALAMINE 800 MG DR TABLET 180S, a pharmaceutical product. The contract has a completion date of January 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award, valued at $1,586.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 24, 2025. It is not designated as a...
This federal contract award, valued at $64,463.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for 4566583099 - MESALAMINE 800 MG DR TABLET 180S, with a firm fixed price and an ultimate completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560970218 - MESALAMINE DR 1.2 GM TABLET 120S, with a ceiling value of $3,478.82 and a period of performance through May 18, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA...
The federal contract award is for the pharmaceutical product "MESALAMINE DR 1.2 GM TABLET 120S", awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order valued at $2,314.88 with a firm fixed price, and has an ultimate completion date of November 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $1,181.45 for the provision of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has a completion date of June 4, 2024 and is a Firm Fixed Price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,360.94 firm fixed-price delivery order is for the supply of MESALAMINE DR 1.2 GM TABLET 120S, a medication used to treat certain gastrointestinal conditions. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of MESALAMINE DR 1.2 GM TABLET 120S. The $1,621.24 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBBJ7
    Delivery Order

This federal contract award, valued at $4,267.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565179499 - MESALAMINE DR 1.2 GM TABLET 120S. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) vehicle with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation and is a Firm Fixed Price contract with a completion date of July 18, 2024.

Generated 10/16/24, 9:09 AM